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Abstract
Background: Aged patients with coronary heart disease (CHD) have a high prevalence of co-morbidity associated with 
poor quality of life, high health care costs, and increased risk for adverse outcomes. These patients are often lacking an 
optimal home care which may result in subsequent readmissions. However, a specific case management programme 
for elderly patients with myocardial infarction (MI) is not yet available. The objective of this trial is to examine the 
effectiveness of a nurse-based case management in patients aged 65 years and older discharged after treatment of an 
acute MI in hospital. The programme is expected to influence patient readmission, mortality and quality of life, and 
thus to reduce health care costs compared with usual care. In this paper the study protocol is described.
Methods/design: The KORINNA (Koronarinfarkt Nachbehandlung im Alter) study is designed as a single-center 
randomized two-armed parallel group trial. KORINNA is conducted in the framework of KORA (Cooperative Health 
Research in the Region of Augsburg). Patients assigned to the intervention group receive a nurse-based follow-up for 
one year including home visits and telephone calls. Key elements of the intervention are to detect problems or risks, to 
give advice regarding a broad range of aspects of disease management and to refer to the general practitioner, if 
necessary. The control group receives usual care. Twelve months after the index hospitalization all patients are re-
assessed. The study has started in September 2008. According to sample size estimation a total number of 338 patients 
will be recruited. The primary endpoint of the study is time to first readmission to hospital or out of hospital death. 
Secondary endpoints are functional status, participation, quality of life, compliance, and cost-effectiveness of the 
intervention. For the economic evaluation cost data is retrospectively assessed by the patients. The incremental cost-
effectiveness ratio (ICER) will be calculated.
Discussion: The KORINNA study will contribute to the evidence regarding the effectiveness of case management 
programmes in aged people with MI. The results can be an important basis for clinicians, administrators and health 
policy makers to decide on the provision of high-quality care to older patients with CHD.
Trial registration: ISRCTN02893746
Background
Coronary heart disease (CHD) in aging populations
The aging of the population and the increasing preva-
lence of chronic diseases imply great challenges to the
health systems of developed countries. CHD is the lead-
ing cause of mortality and morbidity in the industrialized
world. The treatment of acute myocardial infarction (MI)
has improved dramatically over the last 10 to 20 years and
nowadays, aged patients with an acute MI are receiving
treatment that had been limited to mainly younger
patients about a decade ago [1]. Subsequently, the num-
ber of survivors with MI will increase in the next decades.
Patients with CHD, in particular aged patients, have a
h i g h  p r e v a l e n c e  o f  c o - m o r b i d i t y  a s s o c i a t e d  w i t h  p o o r
quality of life, physical disability, high health care costs,
multiple medications, and increased risk for adverse out-
comes. Common co-morbidities among patients with
CHD are diabetes, chronic heart failure (CHF), chronic
obstructive pulmonary disease (COPD), and depression
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[1-3]. CHD is the most common reported cause of
chronic heart failure in all age-groups [4]. A number of
studies also found that more aged than young patients
develop CHF following an acute MI: 47% of those aged
greater than 75 years versus 23% aged < 75 years [5]. In
addition, diabetes is not only a co-morbidity of CHD, but
is also an independent risk factor for the development of
CHF particularly in the aged [6]. CHF is the most com-
mon cause of hospital admission in the aged [7], and
more aged than younger patients with CHF are dis-
charged to long-term care and this number is increasing
[8]. Thus, as a rule, aged patients do not present with an
isolated medical problem, but have multiple co-morbid
diseases [9]. Consequently, these patients receive a num-
ber of medications [10].
Due to changes in the German health care system, in
particular the establishment of the diagnosis related
groups (DRG) system, older patients with complex health
care needs are nowadays discharged earlier from hospital
than a few years ago [11]. For many of these patients an
optimal care at home is not guaranteed, resulting in sub-
sequent readmissions or final admission to a nursing-
home. Medication compliance and lack of medication-
related knowledge are serious problems in aged patients,
and in higher age-groups there is also often a lack of
social support or knowledge to seek medical support
promptly, when specific symptoms appear [12]. Thus,
optimizing care for this population has a high priority.
Many hospital admissions among aged patients with
CHD can be attributed to behavioural and social factors
rather than to deteriorating cardiac function or an inter-
current cardiac event [13]. Thus, aged multimorbid
patients at risk of poor outcomes might benefit from
intensive home follow-up. A nurse-led home-based inter-
vention program including patient education and coun-
selling might improve medication compliance,
medication-related knowledge and thus processes of care,
coronary risk factor profiles, functional status, and qual-
ity of life. As a consequence, this might reduce mortality.
In addition, such a program is expected to reduce health
care resource use in patients with CHD and consequently
total health care expenditures.
Case management programmes for patients with CHD
A number of intervention trials investigated whether a
nurse-based case management may influence patient
readmission and other outcomes in CHD [14,15]. In a
meta-analysis investigating the effectiveness of secondary
prevention programmes with and without exercise com-
ponents 63 randomized trials were included [14]. Almost
all included studies were conducted in patients with CHD
younger than 70 years. It could be shown that secondary
prevention programmes positively affect process of care,
survival, and functional status or quality of life of patients
with CHD independent of the applied programme.
In another review McAlister et al. examined whether
case management programmes for patients with estab-
lished CHD improve the process of care and reduce mor-
tality [15]. In total 12 randomized trials also including
mainly patients younger than 70 years could be identified
by the investigators. It could be demonstrated that com-
prehensive case management programmes have a posi-
t ive  eff ect on pr oc esses of  ca r e in pa t ie n ts  wi t h CHD:
there was a significant reduction in admissions to hospi-
tal and an improvement in quality of life. However, these
randomized clinical trials failed to document any survival
benefit or reduction in recurrent MI.
Although the results of both studies, the meta-analysis
and the review, are promising, these findings can not be
generalized to higher age-groups. Very few studies
reported on case management programmes in people
older than 65 years. The studies by Naylor et al [16,17]
examined a nurse-centered discharge planning and home
follow-up intervention in patients older than 65 years
with a broad variation of diagnoses and interventions.
Their study on older people with CHF (mean age 76
years) demonstrated that the intervention significantly
increased the length of time between hospital discharge
and readmission or death, reduced total number of rehos-
pitalizations, and decreased healthcare costs [17].
Regarding cost-effectiveness of the case management
programmes it is notable that only seven of the 63 trials
included in the meta-analysis by Clark et al. [14]
described the costs of the intervention. Two reported that
their intervention was cost saving but only one has per-
formed formal cost-effectiveness analyses. From the
twelve studies included in the review by McAlister et al.
[15], three described cost data and two reported that
their intervention was cost saving, but none performed
formal cost-effectiveness analyses. Based on the observed
lack of formal economic evaluations in these studies and
the conflicting results, the need to systematically inte-
grate economic evaluations into such studies was high-
lighted by the authors [14,15].
Overall, the review of the literature showed that studies
on case management programmes mostly included par-
ticipants with CHD younger than 70 years [14] or
included persons hospitalized with one of several com-
mon medical and surgical reasons [18,19]. So far, no
intervention trial focused on a specific case management
programme for the group of aged patients after MI. Case
management focuses on delivering personalized services
to patients to improve their care. Case management after
hospital discharge could play a central role for the pre-
vention of re-infarction or readmission for other reasons
among aged patients with an acute MI.Kirchberger et al. BMC Geriatrics 2010, 10:29
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Objective of the study
The primary objective of the study is to assess whether a
c a s e  m a n a g e m e n t  i n t e r v e n t i o n  b y  t r a i n e d  n u r s e s  c a n
reduce time to first readmission or out-of-hospital death
in aged patients with MI. Secondary objectives are the
estimation of the cost-utility ratio of this case manage-
ment intervention and to compare case management vs.
routine care with respect to secondary out-comes such as
functional capacity, participation, quality of life, and
compliance with medication. For patients with specific
comorbidity, additional outcome criteria will be com-
pared between the two groups, e.g. adjustment of blood
glucose values and hemoglobin-A1c in patients with type
2 diabetes, and maintenance of body weight in patients
with CHF.
The aim of this paper is to describe the study protocol
of the KORINNA (Koronarinfarkt-Nachbehandlung im
Alter) study. Patient recruitment in the KORINNA study
has started by September 2008. This detailed description
of the study background and protocol is published as a
reference for forthcoming papers on the study results.
Methods/Design
Study design
The study is designed as a single-centre randomized two-
armed parallel group trial. The study is carried out within
the framework of KORA (Cooperative Health Research in
the Region of Augsburg). All patients receive a baseline
assessment after giving their informed consent. The base-
line assessment is carried out by the study physician and a
study nurse. Those who are subsequently randomized to
the intervention group receive the intervention starting
with the initial session shortly before discharge (see Fig-
ure 1). All patients are contacted by phone after 3, 6, and
9 months in order to document a core set of relevant out-
come measures. The duration of the intervention phase is
one year. After one year a final investigation takes place in
the hospital or at home.
Patient selection
Inclusion criteria
In the KORINNA study all patients of the age group 75
years and older with a first or recurrent MI during the
planned recruitment period who are treated in the Augs-
burg Hospital should be included. The Augsburg Hospital
is the largest hospital in the region of Augsburg - a city
with 300,000 inhabitants in the south of Germany - offer-
ing a coronary care unit as well as coronary angiography
and angioplasty facilities 24 hours a day. All myocardial
infarctions according to ESC and ACC criteria will be
included [20].
However, an unexpected low number of patients of the
age group 75 years and older became apparent during the
first year. As a consequence, the study protocol was mod-
ified and the minimum age of participants was set to 65
years. The recruitment phase needs to be expanded
accordingly. This modification was discussed with the
studies' Advisory Board.
Exclusion criteria
Patients who already live in institutionalized care are
excluded. In addition, patients who already plan to move
into institutional care or outside the study region within
the next months are excluded as well. Furthermore,
patients with severe comorbidity (e.g. terminal cancer)
which makes rehospitalization within the next months
necessary or is associated with a life expectancy of less
than one year, and patients who are not able to communi-
cate in German language are excluded. Finally , patients
who are unable or unwilling to give written informed
consent (e.g. patients with dementia) cannot be included
in the study. The number of patients not included in the
study as well as reasons for exclusion will be documented.
The study protocol and its amendment were approved
b y  t h e  E t h i c s  C o m m i t t e e  a t  t h e  B a v a r i a n  C h a m b e r  o f
Physicians (Date of approval: 11.11.2008, Reference num-
ber: 08064). Furthermore, the study is conducted in
accordance to German privacy law and in compliance
with the Helsinki Declaration.
Randomization
All patients meeting the inclusion criteria and giving
informed consent are randomly assigned to the interven-
tion or control group. The allocation ratio is 1:1. To
ensure the concealment of the allocation, randomization
is provided per telephone call to the biostatistical center
at the Helmholtz Zentrum München, German Research
Center for Environmental Health, where a randomization
list is kept. A minimization procedure is used which tries
to achieve balanced treatment groups with respect to
gender, age (< 70 vs. 70-79 vs. 80+), and number of
comorbidities (diabetes and CHF).
Figure 1 Study design.
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Intervention
The intervention consists of a nurse-led individualized
home-follow up programme with a duration of one year.
The control group receives usual care. Patients can use or
apply for all available services in the area.
Initial session before discharge
The intervention programme starts with an initial infor-
mation session (approximate duration 1 hour) which
takes place one or two days before hospital discharge (see
Figure 1). In this session the patient is first of all provided
with information about the disease and comorbidities,
about medication and with behavioural recommenda-
tions (nutrition, physical activity, smoking etc.). Informa-
tion is given orally and in written form (so-called "heart
book"). If possible, close relatives of the patient may par-
ticipate in the discharge session. A first home visit is
arranged, if accepted by the patient, otherwise an
appointment for a telephone call is made.
Home visits and telephone calls
Home visits (0 to 4) and telephone calls (at least every 3
months) are carried out according to patient need and
patient risk level. At the first home visit the specific prob-
lems of the patient are identified and documented. An
individual plan for each patient is set up. The risk level is
assessed by the study nurse during the first home visit
based on compliance, the social network, and the comor-
bidities. The higher the risk level the more contacts (tele-
phone and home visits) are arranged by the study nurse.
The activities are planned in agreement with the patient
in order to improve compliance.
The first home visit is scheduled to take place 7 to 14
days after discharge. If the patient stays in a rehabilitation
hospital immediately after discharge from the Augsburg
hospital, the first home visit will be postponed accord-
ingly. At the home visits patients are instructed how the
prescribed drugs have to be taken and what would hap-
pen in the case of non-compliance with medication. Fur-
thermore, to patients with diabetes advice is given
regarding nutrition and physical activity, and patients
with CHF are encouraged to regular weight control. Dur-
ing the visits, measurements of blood glucose, blood
pressure, and weight are performed. The duration of the
visit should be between 60 and 90 minutes. The key ele-
ments of both the home visits and the telephone calls are:
to detect problems (e.g. regarding intake of medication)
or risks, to give advice regarding a broad range of aspects
of disease management (e.g. health behaviour) and to
refer to the general practitioner, if necessary. The content
and structure of home visits and telephone calls are com-
parable, and primarily differ regarding location and type
of contact between the patient and nurse, and the possi-
bility to measure blood glucose, blood pressure, and
weight.
Training
In August 2008, a training of the three study nurses and
the study physician was performed lasting several days.
The following topics and diseases were intensively dis-
cussed with the study nurses: CHD, MI, angina pectoris,
heart failure, treatment of MI, risk factors of cardiovascu-
lar diseases, action of particular drugs, diabetes mellitus,
psychological factors and MI. Furthermore, the structure
and the contents of the "Heart book" handed out to the
patients in the intervention group at discharge were dis-
cussed.
Regarding the study implementation, both study physi-
cian and study nurses received a training on patient
recruitment. The study physician was instructed on
patient information and obtaining informed consent.
Moreover, the procedure of the clinical examination and
personal interview was trained.
Finally, study nurses were introduced in the perfor-
mance of personal interviews in the hospital, of home vis-
its, and of telephone interviews, the use of the
intervention modules, the data extraction from patients'
records, documentation, and data entry.
Baseline and outcome assessments
The primary endpoint of readmission is measured as
time between initial hospital discharge and first
unplanned readmission to hospital (at least for 24 hours).
Out of hospital death from any cause is counted as an
event.
The instruments used to assess secondary outcomes
are shown in Table 1. Baseline data on all recruited
patients (intervention and control group) are collected at
the index hospitalization, usually one or two days before
the patient will be discharged. Data on sociodemographic
and health status characteristics, functional status, par-
ticipation, and psychosocial status are collected by the
study physician and a trained study nurse. After dis-
charge, standardized non-interventional telephone inter-
views with the patients in both groups are planned at 3, 6,
and 9 and 12 months after index hospital discharge iden-
tifying patient's readmissions, acute care visits to physi-
cians, clinics, and ambulatory departments. Data on
quality of life is also collected during these interviews. In
the intervention group additional telephone calls as well
a s  h o m e  v i s i t s  t a k e  p l a c e  a s  p a r t  o f  t h e  i n t e r v e n t i o n .
Additional information is documented on these opportu-
nities in order to monitor process quality.
Twelve months after the index hospitalization all
patients who are still alive are invited for a final assess-
ment in the hospital or, if necessary, at home. This exami-
nation includes a personal interview with an assessment
of functional capacity, mental status and quality of life,
adherence to medication, health care utilization, and the
measurement of blood pressure and body weight. TheKirchberger et al. BMC Geriatrics 2010, 10:29
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Table 1: Outcome measures
Category Instrument Reported 
by
T0 T3 T6 T9 T12
Anamnesis Baseline questionnaire Physician •
Anamnesis Geriatric Assessment [26] Physician •
Q u a l i t y  o f  l i f e E Q - 5 D  [ 2 4 ] P a t i e n t •••••
Quality of life WHO-5 Well Being Index (WHO-5) [27] Patient • •
Cognitive functions Mini Mental State Exam (MMSE) [28] Physician • •
ADL Barthel Index [29] Physician • •
IADL Instrumental Activities of Daily Living 
Scale (IADL) [30]
Physician • •
Functioning Health Assessment Questionnaire 
(HAQ-DI) [31]
Patient • •
Functioning Hand grip strength measurement [32] Physician • •
Mobility Timed up and go (TUG) [33] Physician • •
Nutrition Seniors in the Community Risk 
Evaluation for Eating and Nutrition 
(SCREEN II, Version II) [34]
Patient • •
Social Support Fragebogen zur sozialen 
Unterstützung (F-sozU) [35]
Patient • •
Depression Geriatric depression scale (GDS) [36] Patient • •
R e s o u r c e  u s e Q u e s t i o n n a i r e P a t i e n t •••••
study physician and nurse who are involved in the final
assessment are not aware whether the respective patient
was assigned to the intervention- or control group.
Data on resource utilization as well as on quality of life
are collected at baseline, at interim telephone contacts,
and during the final assessment.
Economic evaluation
Data for the economic analysis is collected via patients
and from hospital records. Table 2 summarizes the data
collection for the economic evaluation. As valid informa-
tion on the resource use can only be retrospectively gath-
ered for a short previous time period the assessment of
resource utilization is conducted quarterly.
Within the last years, standardized instruments mea-
suring the resource use were developed such as the RAI
(Resident Assessment Instrument) [21] or the RUD
(Resource utilization of dementia) [22]. Based on these
questionnaires and on our experiences we developed a
questionnaire for the patients that can be used in per-
sonal and telephone interviews.
The valuation of the resource use will be based on the
valuation rates calculated by Krauth et al. [23]. As the val-
uation rates are based on data for the year 2000 the calcu-
lations will be up-dated.
Especially in the economic evaluation of interventions
with the elderly informal care plays an important role.
However, as the assessment is very time consuming and
the interview time should be minimized we refrained
from assessing informal care time. To estimate the cost of
informal care we use the information on a care level
declared by the long term care insurance. If the patient is
allowed to receive nursing care and does not receive for-
mal care, it is assumed that the patient has an informal
caregiver. In that case, the maximum amount for care at
home paid by the long term care insurance will be used as
cost for informal care.
Cost for the intervention excluding the costs caused by
the study will be considered. Cost components will
include labor costs, travel expenses, telephone costs etc.
In order to calculate quality-adjusted life years
(QALYs), the EQ-5D questionnaire [24] is applied at
baseline, at interim telephone contacts, and during the
final assessment. Additionally, the Visual Analogue Scale
(VAS) [24] is applied at baseline and final assessment.
It is planned to perform a cost-utility-analysis from the
societal perspective. This means that incremental costs of
the intervention (vs. control) are set in relation to the
number of QALYs gained. The resulting incremental
cost-effectiveness ratio (ICER) is an international stan-
dard for reporting results of economical evaluation stud-
ies. In addition, we will calculate additional costs per life
year saved and per year without event. For the estimated
ICER value a 95% confidence interval will be calculated
based on bootstrap methods.Kirchberger et al. BMC Geriatrics 2010, 10:29
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Analysis
The statistical analysis for the primary endpoint will
focus on the null hypothesis that there is no difference
between intervention and control with respect to the dis-
tribution of time to un-planned readmission (including
out-of-hospital death). This hypothesis will be statisti-
cally tested using a Cox proportional hazards model
including age, gender, and comorbidity as covariates.
Statistical analyses for secondary outcomes will be
based on (generalized) linear models depending on the
type and distribution of the outcome variable. Since these
will be multiple tests for which control of the overall error
level cannot be achieved, these will be regarded as explor-
atory analyses. All analyses will be done according to the
intent-to-treat approach.
Sample size
Based on a comparable study by Young and colleagues
[25] with patients 70 years of age we expect an event rate
(readmission or out-of-hospital death) of 40% in the con-
trol group. If the study is designed to have 80% power or
more to detect an improved rate of 25% in the interven-
tion group (i.e. Δ = 0.15) at a two-sided type I error level
of 5%, at least 152 patients per group will be needed. We
expect that the drop-out rate does not exceed 10% during
the 1-year follow-up period. In order to allow for loss to
follow-up (patient withdrawing consent or moving away
from study region), it is planned to recruit a total of 338
patients for the trial.
Discussion
This paper describes the study design of the KORINNA
study, an innovative randomized controlled trial evaluat-
ing the effectiveness of a nurse-based case management
programme for old-aged patients with MI. The
KORINNA study is unique in a twofold way.
First, the nurse-led case management is tailored to the
specific needs of old-aged people with MI. The interven-
tions specifically address common challenges and risks
associated with the MI management in elderly people
such as multi-morbidity and compliance with medica-
tion. Further, the programme is flexible regarding fre-
quency and location of the intervention. Thus, when
deciding on the number of interventions necessary or
whether a home-visit or telephone call is more appropri-
ate, the nurse can take the individual health and living
condition of a patient into account. Our experiences
gathered from approximately 100 patients who have
already received interventions within the study, confirm
the need for a highly individualized intervention pro-
gramme. Until now, a broad range of health states and
impairments among the study participants could be
observed which necessitates a variable intervention
intensity.
Second, a particular strength of this study relates to the
planned economic evaluation. In view of scarce financial
resources within the German health system it is essential
that innovative models of care not only demonstrate pos-
itive effects on clinical and patient-related outcomes but
also cost-effectiveness. Since cost savings have already
been shown in comparable studies in other countries, the
economic results of this study are highly anticipated.
A possible limitation of the study design refers to the
relatively short follow-up interval of one year. It is still
unclear whether the expected positive intervention
effects on readmission to hospital or death can already be
observed within this time interval. Hence, a prolongation
of the study with a follow-up interval of 3 years is already
taken into consideration. A further limitation of the study
is its single center design.
So far , we have experienced an unexpected challenge
regarding the number of eligible patients aged 75 years
Table 2: Overview on the cost categories, the measurement of the resource use and its valuation
Cost category Resource use Valuation
Outpatient care Number of consultations n per consultation
Prescribed drugs Central pharmaceutical number, ATC 
code, dose rate
Pharmacy retail price
Inpatient care Length of stay and number of days on the 
intensive care unit, if applicable DRG
Daily hospital rate, if applicable DRG
Rehabilitation (excluding primary rehab) Length of stay Daily rehabilitation rate
Remedies (physiotherapy, massage) Number of visits Average rates
Ambulatory care Days per week and performed activities (or 
hours per day)
Average rates for activities (or hours)
Home help Hours per week Average labor costs for a home help
Informal care Care level declared by the long term care 
insurance
Max amount paid by the long term care 
insurance if the patient does not make use 
of formal careKirchberger et al. BMC Geriatrics 2010, 10:29
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and older. Some months after starting recruitment it
became apparent that the planned sample size cannot be
reached within the expected time frame. We discussed
this problem with the members of the studies' advisory
board and decided to decrease the minimum age of study
participants from 75 years to 65 years. As a consequence
of the initially low number of patients who could be
included in the study, the recruitment phase will be
extended by several months. In addition, the number of
patients who could not be included due to severe con-
comitant diseases or dementia (20%), or since they were
already nursing home residents (10%), was higher than
expected. On the other hand, the number of study
patients who were lost to follow-up within the one-year
treatment course currently is 7% and therefore even
lower than initially expected. In addition, we have noticed
that the home visits as well as telephone calls are very
well accepted by the patients. These findings indicate a
good acceptance and feasibility of the study.
In summary, the KORINNA study is expected to con-
tribute to the evidence regarding the effectiveness of
nurse-based case management programmes for aged
patients with MI. The results can be an important basis
for clinicians, administrators and health policy makers to
decide on the provision of high-quality care to older
patients with MI.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
CM, BK and RH initiated the study and raised the research grant. CM and BK are
principal clinical investigators, RH is principal statistical investigator. CM and BK
developed the case-management programme. CM, RH, BK, RW, HS contributed
to conception and design of the study. HS is responsible for the economic
evaluation and for study monitoring. RW is study physician and responsible for
patient recruitment and clinical examination/assessment. IK is in charge of the
local coordination of the study and wrote the manuscript. All authors critically
revised and approved the final manuscript.
Acknowledgements
The present trial is conducted within subproject 2 of the research cooperation 
KORA-Age and is funded by the German Federal Ministry of Education and 
Research (01 ET 0703). The KORA research platform is financed by the Helm-
holtz Zentrum München, German Research Center for Environmental Health 
(GmbH), which is funded by the German Federal Ministry of Education, Sci-
ence, Research and Technology and by the State of Bavaria. We thank all mem-
bers of the Helmholtz Zentrum München who are involved in the conduct of 
the study. Furthermore, we wish to thank the field staff in Augsburg, especially 
Martina Bernstein, Barbara Dick, Claudia Greschik, Birgit Kling, Dorothea 
Lukitsch, Sonja Reiserer, and Gisela Sietas.
Author Details
1Institute of Epidemiology, Helmholtz Zentrum München, German Research 
Center for Environmental Health, Neuherberg, Germany, 2MONICA/KORA 
Myocardial Infarction Registry, Central Hospital of Augsburg, Augsburg, 
Germany, 3Institute of Health Economics and Health Care Management, 
Helmholtz Zentrum München, German Research Center for Environmental 
Health, Neuherberg, Germany and 4Department of Internal Medicine I - 
Cardiology, Central Hospital of Augsburg, Augsburg, Germany
References
1. Zeymer U, Gitt A, Winkler R, Zahn R, Junger C, Schiele R, Gottwik M, 
Senges J: Mortality of patients who are older than 75 years after ST 
elevation myocardial infarction in clinical practice.  DMW 2005, 
130:633-636.
2. Botkin NF, Spencer FA, Goldberg RJ, Lessard D, et al.: Changing trends in 
the long-term prognosis of patients with acute myocardial infarction: 
A population-based perspective.  Am Heart J 2006, 151:199-205.
3. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, et al.: 
Even minimal symptoms of depression increase mortality risk after 
acute myocardial infarction.  American J of Cardiol 2001, 88:337-341.
4. Kupari M, Lindroos M, Iivanainen AM, Heikkila J, Tilvis R: Congestive heart 
failure in old age: Prevalence, mechanisms and 4-year prognosis in the 
Helsinki Ageing Study.  J Int Med 1997, 241:387-94.
5. Rash Madsen C, Jensen G, Kober L, Melchior T, Torp Pedersen C, 
Hildebrand P: Age-related mortality, clinical heart failure, and 
ventricular fibrillation in 4259 Danish patients after acute myocardial 
infarction.  Eur Heart J 1997, 18:1426-31.
6. Bell DSH: Diabetic Cardiomyopathy.  Diabetes Care 2003, 29:49-51.
7. Rodriguez Artalejo F, Guallar Castillon P, Banegas JRB, Calero JD: Trends in 
hospitalization and mortality for heart failure in Spain, 1980-1993.  Eur 
Heart J 1997, 18:1771-9.
8. Haldemann GA, Croft JB, Giles WH, Rashidee A: Hospitalization of 
patients with heart failure: National Hospital Discharge Survey, 1985-
1995.  Am Heart J 1999, 137:352-60.
9. Gooding J, Jette AM: Hospital readmission among the elderly.  J Am Ger 
Soc 1985, 33:595-601.
10. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, Bos GA 
van den: Causes and consequences of comorbidity: a review.  J Clin 
Epidemiol 2001, 54:661-674.
11. Jonitz G: Impact of rationing on health care during the last years of life.  
Z Evid Fortbild Qual Gesundhwes 2008, 102(3):200-3.
12. Ashton CM, Kuykendall DH, Johnson ML, Wray NP, Wu L: The association 
between the quality of inpatient care and early readmission.  Ann Intern 
Med 1995, 122:415-21.
13. Petrie MC, Berry C, Stewart S, McMurray JJV: Failing ageing heart.  Eur 
Heart J 2001, 22:1978-1990.
14. Clark AM, Hartling L, Vandermeer B, McAlister FA: Meta-analysis: 
secondary prevention programs for patients with coronary artery 
disease.  Ann Int Med 2005, 143(9):659-72.
15. McAlister FA, Lawson FM, Teo KK, Armstrong PW: Randomised trials of 
secondary prevention programmes in coronary heart disease: 
systematic review.  BMJ 2001, 323:957-62.
16. Naylor MD, Brooten D, Campbell R, Jacobsen BS, Mezey MD, Pauly MV, 
Schwartz JS: Comprehensive discharge planning and home follow-up 
of hospitalized elders: a randomized clinical trial.  JAMA 1999, 
281:613-20.
17. Naylor MD, Brooten DA, Campbell RL, Maislin G, McCauley KM, Schwartz 
JS: Transitional care of older adults hospitalized with heart failure: a 
randomized, controlled trial.  J Am Geriatr Soc 2004, 52:675-84.
18. Preen DB, Bailey BE, Wright A, Kendall P, Phillips M, Hung J, Hendriks R, 
Mather A, Williams E: Effects of a multidisciplinary, post-discharge 
continuance of care intervention on quality of life, discharge 
satisfaction, and hospital length of stay: a randomized controlled trial.  
Int J Qual Health Care 2005, 17:43-51.
19. Lim WK, Lambert SF, Gray LC: Effectiveness of case management and 
post-acute services in older people after hospital discharge.  Med J Aust 
2003, 178(6):262-6.
20. Lowel H, Meisinger C, Heier M, Hormann A: The population-based acute 
myocardial infarction (AMI) registry of the MONICA/KORA study region 
of Augsburg.  Gesundheitswesen 2005, 67(Suppl 1):S31-7.
21. Ljunggren G, Morris J: The Resident Assessment Instrument (RAI) and 
resource use in dementia care.  In Health Economics of Dementia Edited 
by: Wimo AJB, Karlsson G, Winblad B. Chichester: John Wiley & Sons; 1998. 
22. Wimo A, Wetterholm AL, Mastey V, Winblad B: Evaluation of the 
Healthcare Resource and Caregiver Time in Anti-Dementia Drug Trials - 
A Quantitative Battery.  In Health Economics of Dementia Edited by: Wimo 
A, Jönsson B, Karlsson G, Winblad B. Chichester: John Wiley & Sons,; 
1998:465-99. 
23. Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B: Empirical 
standard costs for health economic evaluation in Germany -- a  Received: 28 January 2010 Accepted: 27 May 2010 
Published: 27 May 2010
This article is available from: http://www.biomedcentral.com/1471-2318/10/29 © 2010 Kirchberger et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. BMC Geriatrics 2010, 10:29Kirchberger et al. BMC Geriatrics 2010, 10:29
http://www.biomedcentral.com/1471-2318/10/29
Page 8 of 8
proposal by the working group methods in health economic 
evaluation.  Gesundheitswesen 2005, 67:736-46.
24. The EuroQol Group: EuroQol--a new facility for the measurement of 
health-related quality of life.  In Health Policy Volume 16. The EuroQol 
Group; 1990:199-208. 
25. Young W, Rewa G, Goodman SG, Jaglal SB, Cash L, Lefkowitz C, Coyte PC: 
Evaluation of a community-based inner-city disease management 
program for postmyocardial infarction patients: a randomized 
controlled trial.  CMAJ 2003, 169:905-10.
26. Lachs MS, Feinstein AR, Cooney LM Jr, Drickamer MA, Marottoli RA, Pannil 
FC, et al.: A simple procedure for general screening for functional 
disability in elderly patients.  Ann Intern Med 1990, 112:699-706.
27. Bonsignore M, Barkow K, Jessen F, Heun R: Validity of the five-item WHO 
Well-Being Index (WHO-5) in an elderly population.  Eur Arch Psychiatry 
Clin Neurosci 2001, 251(Suppl 2):II27-31.
28. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical 
method for grading the cognitive state of patients for the clinician.  
Journal of Psychiatric Research 1975, 12:189-98.
29. Mahoney FI, Barthel DW: Functional Evaluation: The Barthel Index.  Md 
State Med J 1965, 14:61-5.
30. Lawton MP, Brody EM: Assessment of older people: self-maintaining 
and instrumental activities of daily living.  Gerontologist 1969, 9:179-86.
31. Bruhlmann P, Stucki G, Michel BA: Evaluation of a German version of the 
physical dimensions of the Health Assessment Questionnaire in 
patients with rheumatoid arthritis.  J Rheumatol 1994, 21:1245-9.
32. Stel VS, Smit JH, Pluijm SM, Lips P: Balance and mobility performance as 
treatable risk factors for recurrent falling in older persons.  J Clin 
Epidemiol 2003, 56:659-68.
33. Podsiadlo D, Richardson S: The timed "Up & Go": a test of basic 
functional mobility for frail elderly persons.  J Am Geriatr Soc 1991, 
39:142-8.
34. Keller HH, Goy R, Kane SL: Validity and reliability of SCREEN II. Seniors in 
the community: risk evaluation for eating and nutrition, Version II.  Eur J 
Clin Nutr 2005, 59:1149-57.
35. Fydrich T, Sommer G, Tydecks S, Brähler E: Fragebogen zur sozialen 
Unterstützung (F-SozU): Normierung der Kurzform (K-14).  Z Med 
Psychol 2009, 18:43-48.
36. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO: 
Development and validation of a geriatric depression screening scale: 
a preliminary report.  J Psychiatr Res 1982, 17:37-49.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2318/10/29/prepub
doi: 10.1186/1471-2318-10-29
Cite this article as: Kirchberger et al., Nurse-based case management for 
aged patients with myocardial infarction: study protocol of a randomized 
controlled trial BMC Geriatrics 2010, 10:29